Literature DB >> 13260677

Use of reserpine and Rauwolfia in psychoneuroses.

A FOLKSON, A R MAY.   

Abstract

Entities:  

Keywords:  NEUROSES/therapy; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh：

Substances：

Year:  1955        PMID： 13260677      PMCID： PMC1981342          DOI： 10.1136/bmj.2.4948.1121

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  8 in total

1.  The neurasthenic psychopath.

Authors:  W L TONGE
Journal:  Br Med J       Date:  1955-04-30

2.  Reserpine in treatment of chronic psychotics; preliminary observations.

Authors:  E S FOOTE
Journal:  Br Med J       Date:  1955-05-14

3.  An extrapyramidal syndrome with reserpine.

Authors:  A RICHMAN; J S TYHURST
Journal:  Can Med Assoc J       Date:  1955-03-15       Impact factor: 8.262

4.  Mental depression in hypertensive patients treated for long periods with large doses of reserpine.

Authors:  E D FREIS
Journal:  N Engl J Med       Date:  1954-12-16       Impact factor: 91.245

5.  The use and action of chlorpromazine in psychoneuroses.

Authors:  G GARMANY; A R MAY; A FOLKSON
Journal:  Br Med J       Date:  1954-08-21

6.  Use of Rauwolfia serpentina Benth. in neuropsychiatric conditions.

Authors:  N S KLINE
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

7.  A clinical trial of Rauwolfia serpentina in essential hypertension.

Authors:  R J VAKIL
Journal:  Br Heart J       Date:  1949-10

8.  Reserpine (serpasil) in the management of the mentally ill and mentally retarded; preliminary report.

Authors:  R H NOCE; D B WILLIAMS; W RAPAPORT
Journal:  J Am Med Assoc       Date:  1954-10-30
  8 in total
  3 in total

1.  The use of tranquillizers.

Authors:  A R MAY
Journal:  Postgrad Med J       Date:  1957-10       Impact factor: 2.401

2.  Anxiety states.

Authors:  G GARMANY
Journal:  Br Med J       Date:  1956-04-28

3.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1955-12-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.